When standard chemotherapy did not work for Roy Vinke, he and his family began to research other treatments.
They had Roy’s tumor sent for molecular profiling. Sure enough he had a mismatch repair deficiency, which made immunotherapy an option for treatment. Roy has responded well and now helps other patients facing pancreatic cancer.
Read more about Roy in “Genomic Profiling of my Pancreatic Cancer Gave me a New Lease on Life.”
What new treatments and clinical trials are available to me?
Share Your Story.
Help others by sharing your experiences.